CCA cells (KKU‐213 and KKU‐214) were treated with PUGNAc for 24 h, and the OGP level together with migration and invasion abilities of CCA cells treated with or without PUGNAc was determined. This evidence concerns the gene OVGP1 and cholangiocarcinoma.